Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 16, 2022 07:31 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag OssDsign redovisar positiva data från långtidsuppföljning med OssDsign Cranial PSI

STOCKHOLM, SVERIGE 16 december 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar att portföljbolaget OssDsign presenterat uppdaterade avvikelsedata från en långtidsuppföljning av...
December 16, 2022 07:31 ET | Source: Karolinska Development AB (publ)

Karolinska Development's portfolio company OssDsign has presented positive long-term data for OssDsign Cranial PSI

STOCKHOLM, SWEDEN, December 16, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has presented updated post-market surveillance from a long-term...
November 29, 2022 17:38 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag OssDsign har genomfört en riktad nyemission om cirka 65,6 miljoner kronor

STOCKHOLM, SVERIGE 29 november 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar att portföljbolaget OssDsign har genomfört en riktad nyemission om cirka 65,6 miljoner kronor till ett...
November 29, 2022 17:38 ET | Source: Karolinska Development AB (publ)

Karolinska Development's portfolio company OssDsign has completed a directed share issue of approximately SEK 65.6 million

STOCKHOLM, SWEDEN, November 29, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has completed a directed share issue of approximately SEK 65.6...
November 18, 2022 02:00 ET | Source: Karolinska Development AB (publ)

Delårsrapport för januari – september 2022

STOCKHOLM – den 18 november 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) publicerar idag sin delårsrapport för januari - september 2022. Den fulla rapporten är tillgänglig på bolagets...
November 18, 2022 02:00 ET | Source: Karolinska Development AB (publ)

Interim Report - January-September 2022

STOCKHOLM – 18 November 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report - January-September 2022. The full report is available on the Company's website. ...
October 24, 2022 02:30 ET | Source: Karolinska Development AB (publ)

Karolinska Development investerar i det danska dermatologibolaget Henlez

STOCKHOLM, SVERIGE 24 oktober 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar att bolaget deltagit i en såddfinansiering av Henlez, ett privatägt danskt företag som fokuserar på ett...
October 24, 2022 02:30 ET | Source: Karolinska Development AB (publ)

Karolinska Development invests in the Danish dermatology company Henlez

STOCKHOLM, SWEDEN, October 24, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today its participation in a seed financing of Henlez, a privately owned Danish company focusing on a...
September 28, 2022 02:30 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag Umecrine Cognition presenterar positiva prekliniska studieresultat för golexanolon

STOCKHOLM, SVERIGE 28 september 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Umecrine Cognition presenterat nya prekliniska resultat som ger ytterligare...
September 28, 2022 02:30 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company Umecrine Cognition presents positive results from a preclinical study of golexanolone

STOCKHOLM, SWEDEN – September 28, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has presented new preclinical results that...